UBS Reiterates Buy Rating on Oracle (ORCL) Following CFO Appointment
Go back to UBS Reiterates Buy Rating on Oracle (ORCL) Following CFO Appointment| Oracle Corp. (NYSE: ORCL) | Delayed: 179.53 -4.76 (2.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $184.29 | 52 Week High | $42.00 | |||
| Open | $182.31 | 52 Week Low | $33.13 | |||
| Day High | $184.58 | P/E | 76.72 | |||
| Day Low | $179.38 | EPS | $2.34 | |||
| Volume | 5,486,645 | |||||
